Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2023

Caitlin E. Cox

December 28, 2023

News Daily News

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

Michael O'Riordan

November 21, 2023

News Daily News

Mortality Risk Varies Among Patients With Very High LDL Levels

Michael O'Riordan

November 17, 2023

News Conference News AHA 2023

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

Todd Neale

November 11, 2023

News Daily News

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Michael O'Riordan

September 29, 2023

News Daily News

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

Todd Neale

September 12, 2023

News Conference News ESC 2023

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

Shelley Wood

August 25, 2023

News Daily News

A Mix of Aerobic and Strength Exercise Is Best for Boosting Survival

Caitlin E. Cox

August 09, 2023

News Daily News

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

Michael O'Riordan

July 24, 2023

News Conference News ADA 2023

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

Shelley Wood

June 29, 2023

News Conference News ADA 2023

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

L.A. McKeown

June 28, 2023

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

L.A. McKeown

April 19, 2023

News Daily News

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Yael L. Maxwell

April 12, 2023

News Daily News

Sugar Substitute Erythritol Linked to Cardiac Risk

Yael L. Maxwell

March 15, 2023

News Conference News ACC 2023

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Michael O'Riordan

March 14, 2023

News Daily News

Food Insecurity May Drive Heart Failure, CAD Risks in Black Individuals

L.A. McKeown

February 06, 2023

News Daily News

AHA Annual Statistics Show COVID’s Disruptive Impact

L.A. McKeown

January 30, 2023

Advertisement

TCTMD’s Top 10 Most Popular Stories for December 2023

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

Mortality Risk Varies Among Patients With Very High LDL Levels

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

A Mix of Aerobic and Strength Exercise Is Best for Boosting Survival

CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Sugar Substitute Erythritol Linked to Cardiac Risk

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Food Insecurity May Drive Heart Failure, CAD Risks in Black Individuals

AHA Annual Statistics Show COVID’s Disruptive Impact

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content